Amongst these, it will be critical to dissect the possible link between tau dysregulated clearance, altered inflammatory response and development of tau aggregates around cerebral BVs, in neurodegenerative diseases, including AD and other tauopathies, such as PiD, PSP, and CTE. Here, MAPT is linked to neurodegenerative disease.